US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Neurochem - Common Shares (MM) (NRMX)
Neurochem - Common Shares (MM) (NRMX) ニュース

NRMX

Neurochem (NRMX)

Neurochem - Common Shares (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NRMX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2008/04/17	00 : 57	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/04/15	21 : 00	PR Newswire (US)	At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o	NASDAQ:NRMX
2008/04/12	05 : 27	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/04/12	03 : 30	PR Newswire (US)	Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008	NASDAQ:NRMX
2008/04/12	01 : 24	PR Newswire (US)	Neurochem Annual and Special Meeting of shareholders	NASDAQ:NRMX
2008/04/11	00 : 26	Edgar (US Regulatory)	Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/21	01 : 48	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/15	06 : 23	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/15	06 : 07	Edgar (US Regulatory)	Neurochem Inc - Annual Report (foreign private issuer) (40-F)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/14	04 : 25	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/13	20 : 00	PR Newswire (US)	Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis	NASDAQ:NRMX
2008/02/23	04 : 10	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/22	09 : 19	PR Newswire (US)	Neurochem announces departure of two members of management team	NASDAQ:NRMX
2008/02/22	06 : 54	Edgar (US Regulatory)	Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/22	05 : 18	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/21	09 : 12	PR Newswire (US)	Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives	NASDAQ:NRMX
2008/02/16	05 : 45	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/14	02 : 26	PR Newswire (US)	/C O R R E C T I O N from source -- Neurochem Inc./	NASDAQ:NRMX
2008/02/12	05 : 55	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/12	00 : 46	PR Newswire (US)	Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live	NASDAQ:NRMX
2008/01/31	06 : 26	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/01/30	22 : 00	PR Newswire (US)	Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business	NASDAQ:NRMX
2008/01/04	05 : 59	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/01/04	03 : 08	PR Newswire (US)	Neurochem to present at JPMorgan Healthcare Conference	NASDAQ:NRMX
2007/12/15	05 : 51	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2007/12/14	22 : 24	PR Newswire (US)	Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis	NASDAQ:NRMX
2007/12/08	07 : 25	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2007/12/07	07 : 09	PR Newswire (US)	Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review	NASDAQ:NRMX
2007/12/04	05 : 05	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2007/12/01	06 : 15	PR Newswire (US)	Neurochem announces departure of Dr. Philippe Calais, President, Global Business	NASDAQ:NRMX

Showing the most relevant articles for your search:NASDAQ:NRMX

1 2 3 4 5 6 次へ >>

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Verizon Communications

Health Care Select Sector

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約